|
[1]中华医学会.非酒精性脂肪性肝病诊疗指南[J].中华肝脏杂志, 2010, 18 (3) :163-170.
|
|
[1]中华医学会.非酒精性脂肪性肝病诊疗指南[J].中华肝脏杂志, 2010, 18 (3) :163-170.
|
|
[2]American Colleges of Endocrinology.ACE Position Statementon the Insulin Resistance Syndrome[S].Endocrine Practice, 2003, 9 (3) :240-252.
|
|
[2]American Colleges of Endocrinology.ACE Position Statementon the Insulin Resistance Syndrome[S].Endocrine Practice, 2003, 9 (3) :240-252.
|
|
[3]Petta S, Muratore C, CraxìA.Non-alcoholic fatty liver dis-ease pathogenesis:The present and the future[J].Diges-tive and Liver Disease, 2009, 41 (9) :615-625.
|
|
[3]Petta S, Muratore C, CraxìA.Non-alcoholic fatty liver dis-ease pathogenesis:The present and the future[J].Diges-tive and Liver Disease, 2009, 41 (9) :615-625.
|
|
[4]王燕, 陆伦根.非酒精性脂肪性肝病分子机制研究进展[J].Chin J Gastroenterol, 2010, 15 (4) :246-248.
|
|
[4]王燕, 陆伦根.非酒精性脂肪性肝病分子机制研究进展[J].Chin J Gastroenterol, 2010, 15 (4) :246-248.
|
|
[5]陈洁, 陈东风.非酒精性脂肪性肝病发病机制的部分进展[J].重庆医学, 2009, 38 (15) :1956-1958.
|
|
[5]陈洁, 陈东风.非酒精性脂肪性肝病发病机制的部分进展[J].重庆医学, 2009, 38 (15) :1956-1958.
|
|
[6]Machado M, Marques-Vidal P, Cortez-Pinto H.Hepatichistology in obese patients undergoing bariatric surgery[J].J Hepatol, 2006, 45 (4) :600-606.
|
|
[6]Machado M, Marques-Vidal P, Cortez-Pinto H.Hepatichistology in obese patients undergoing bariatric surgery[J].J Hepatol, 2006, 45 (4) :600-606.
|
|
[7]邹大进, 吴鸿.腹型肥胖致胰岛素抵抗的机制及治疗展望[J].中国糖尿病杂志, 2006, 14 (4) :309-312.
|
|
[7]邹大进, 吴鸿.腹型肥胖致胰岛素抵抗的机制及治疗展望[J].中国糖尿病杂志, 2006, 14 (4) :309-312.
|
|
[8]赵维刚, 朱慧娟.胖致胰岛素抵抗和高血糖的机制、治疗及评测[J].中国医学科学院学报, 2010, 32 (1) :7-11.
|
|
[8]赵维刚, 朱慧娟.胖致胰岛素抵抗和高血糖的机制、治疗及评测[J].中国医学科学院学报, 2010, 32 (1) :7-11.
|
|
[9]Qatanani M, Lazar MA.Mechanisms ofobesity-associatedinsulin resistance:many choices on the menu[J].Genes&Dev, 2007, 21:1443-1455.
|
|
[9]Qatanani M, Lazar MA.Mechanisms ofobesity-associatedinsulin resistance:many choices on the menu[J].Genes&Dev, 2007, 21:1443-1455.
|
|
[10]Schreuder TC, Verwer BJ, van Nieuwkerk CM, et al.Nonal-coholic fatty liver disease:An overview of current insights inpathogenesis, diagnosis and treatment[J].World J Gastro-enterol, 2008, 14 (16) :2474-2486.
|
|
[10]Schreuder TC, Verwer BJ, van Nieuwkerk CM, et al.Nonal-coholic fatty liver disease:An overview of current insights inpathogenesis, diagnosis and treatment[J].World J Gastro-enterol, 2008, 14 (16) :2474-2486.
|
|
[11]Després JP, Lemieux I, Bergeron J, et al.Abdominal obesi-ty and the metabolic syndrome:contribution to global cardio-metabolic risk[J].Arterioscler Thromb Vasc Biol, 2008, 28 (6) :1039-1049.
|
|
[11]Després JP, Lemieux I, Bergeron J, et al.Abdominal obesi-ty and the metabolic syndrome:contribution to global cardio-metabolic risk[J].Arterioscler Thromb Vasc Biol, 2008, 28 (6) :1039-1049.
|
|
[12]Zivkovic AM, German JB, Sanyal AJ.Comparative review ofdiets for the metabolic syndrome:implications for nonalco-holic fatty liver disease[J].Am J Clin Nutr, 2007, 86 (2) :285-300.
|
|
[12]Zivkovic AM, German JB, Sanyal AJ.Comparative review ofdiets for the metabolic syndrome:implications for nonalco-holic fatty liver disease[J].Am J Clin Nutr, 2007, 86 (2) :285-300.
|
|
[13]McAuley K, Mann J.Nutritional determinants of insulin re-sistance[J].J Lipid Res, 2006, 47:1668-1676.
|
|
[13]McAuley K, Mann J.Nutritional determinants of insulin re-sistance[J].J Lipid Res, 2006, 47:1668-1676.
|
|
[14]Mendoza JA, Drewnowski A, Christakis DA.Dietary energydensity is associated with obesity and the metabolic syn-drome in U.S.adults[J].Diabetes Care, 2007, 30 (4) :974-979.
|
|
[14]Mendoza JA, Drewnowski A, Christakis DA.Dietary energydensity is associated with obesity and the metabolic syn-drome in U.S.adults[J].Diabetes Care, 2007, 30 (4) :974-979.
|
|
[15]Valtuena S, Pellegrini N, Ardigo D, et al.Dietary glycemicindex and liver steatosis[J].Am J Clin Nutr, 2006, 84 (1) :136-142.
|
|
[15]Valtuena S, Pellegrini N, Ardigo D, et al.Dietary glycemicindex and liver steatosis[J].Am J Clin Nutr, 2006, 84 (1) :136-142.
|
|
[16]Vilar L, Oliveira CP, Faintuch J, et al.High-fat diet:a trig-ger of non-alcoholic steatohepati-tis?Preliminary findingsin obese subjects[J].Nutrition, 2008, 24 (11-12) :1097-1102.
|
|
[16]Vilar L, Oliveira CP, Faintuch J, et al.High-fat diet:a trig-ger of non-alcoholic steatohepati-tis?Preliminary findingsin obese subjects[J].Nutrition, 2008, 24 (11-12) :1097-1102.
|
|
[17]Marchesini G, Brizi M, Bianchi G, et al.Nonalcoholic fattyliver diseasea feature of the metabolic syndrome[J].Diabe-tes, 2001, 50 (18) :1844-1850.
|
|
[17]Marchesini G, Brizi M, Bianchi G, et al.Nonalcoholic fattyliver diseasea feature of the metabolic syndrome[J].Diabe-tes, 2001, 50 (18) :1844-1850.
|
|
[18]Targher G, Bertolini L, Padovani R, et al.Prevalence of non-alcoholic fatty liver disease and its association with cardiovas-cular disease among type 2 diabetic patients[J].DiabetesCare, 2007, 30 (5) :1212-1218.
|
|
[18]Targher G, Bertolini L, Padovani R, et al.Prevalence of non-alcoholic fatty liver disease and its association with cardiovas-cular disease among type 2 diabetic patients[J].DiabetesCare, 2007, 30 (5) :1212-1218.
|
|
[19]Nestel P, Lyu R, Low LP, et al.Metabolic syndrome:re-cent prevalence in East and Southeast Asian populations[J].Asia Pac J Clin Nutr, 2007, 16 (2) :362-367.
|
|
[19]Nestel P, Lyu R, Low LP, et al.Metabolic syndrome:re-cent prevalence in East and Southeast Asian populations[J].Asia Pac J Clin Nutr, 2007, 16 (2) :362-367.
|
|
[20]Donnelly KL, Smith CI, Schwarzenberg SJ, et al.Sourcesof fatty acids stored in liver and secreted via lipoproteins inpatients with nonalcoholic fatty liver disease[J].J Clin In-vest, 2005, 115 (5) :1343-1351.
|
|
[20]Donnelly KL, Smith CI, Schwarzenberg SJ, et al.Sourcesof fatty acids stored in liver and secreted via lipoproteins inpatients with nonalcoholic fatty liver disease[J].J Clin In-vest, 2005, 115 (5) :1343-1351.
|
|
[21]Park SH, Kim BI, Kim SH, et al.Body fat distribution and in-sulin resistance:beyond obesity in nonalcoholic fatty liverdisease among overweight men[J].J Am Col Nutr, 2007, 26 (4) :321-326.
|
|
[21]Park SH, Kim BI, Kim SH, et al.Body fat distribution and in-sulin resistance:beyond obesity in nonalcoholic fatty liverdisease among overweight men[J].J Am Col Nutr, 2007, 26 (4) :321-326.
|
|
[22]Salgado AL, Carvalho L, Oliveira AC, et al.Insulin resistanceindex (HOMA-IR) in the differentiation of patients with non-alcoholic fatty liver disease and healthy individuals[J].ArgGastroenterol, 2010, 47 (2) :165-169.
|
|
[22]Salgado AL, Carvalho L, Oliveira AC, et al.Insulin resistanceindex (HOMA-IR) in the differentiation of patients with non-alcoholic fatty liver disease and healthy individuals[J].ArgGastroenterol, 2010, 47 (2) :165-169.
|
|
[23]Hwang JH, Stein DT, Barzilai N, et al.Increased intrahepatictriglyceride is associated with peripheral insulin resistance:invivo MR imaging and spectroscopy studies[J].Am J PhysiolEndocrinol Metab, 2007, 293 (6) :E1663-E1669.
|
|
[23]Hwang JH, Stein DT, Barzilai N, et al.Increased intrahepatictriglyceride is associated with peripheral insulin resistance:invivo MR imaging and spectroscopy studies[J].Am J PhysiolEndocrinol Metab, 2007, 293 (6) :E1663-E1669.
|
|
[24]Musso G, Gambino R, Bo S, et al.Should nonalcoholic fattyliver disease be included in the definition of metabolic syn-drome?[J].Diabetes Care, 2008, 31 (3) :562-568.
|
|
[24]Musso G, Gambino R, Bo S, et al.Should nonalcoholic fattyliver disease be included in the definition of metabolic syn-drome?[J].Diabetes Care, 2008, 31 (3) :562-568.
|
|
[25] Esteghamati A, Noshad S, Khalilzadeh O, et al.Insulin re-sistance is independently associated with liver aminotrans-ferases in diabetic patients without ultrasound signs of nonal-coholic fatty liver disease[J].Prev Med, 2011, 52 (2) :174-177.
|
|
[25] Esteghamati A, Noshad S, Khalilzadeh O, et al.Insulin re-sistance is independently associated with liver aminotrans-ferases in diabetic patients without ultrasound signs of nonal-coholic fatty liver disease[J].Prev Med, 2011, 52 (2) :174-177.
|
|
[26]Liu Q, Bengmark S, Qu S.The role of hepatic fat accumula-tion in pathogenesis of non-alcoholic fatty liver disease[J].Lipids Health Dis, 2010, 9:42.
|
|
[26]Liu Q, Bengmark S, Qu S.The role of hepatic fat accumula-tion in pathogenesis of non-alcoholic fatty liver disease[J].Lipids Health Dis, 2010, 9:42.
|
|
[27] Targher G, Bertolini L, Felice Poli, et al.Nonalcoholic fattyliver disease and risk of future cardiovascular events amongtype 2 diabetic patients[J].Diabetes, 2005, 54 (12) :3541-3546.
|
|
[27] Targher G, Bertolini L, Felice Poli, et al.Nonalcoholic fattyliver disease and risk of future cardiovascular events amongtype 2 diabetic patients[J].Diabetes, 2005, 54 (12) :3541-3546.
|
|
[28]Vozarova B, Stefan N, Lindsay RS, et al.High alanine amin-otransferase is associated with decreased hepatic insulin sen-sitivity and predicts the development of type 2 diabetes[J].Diabetes, 2002, 51 (6) :1889-1895.
|
|
[28]Vozarova B, Stefan N, Lindsay RS, et al.High alanine amin-otransferase is associated with decreased hepatic insulin sen-sitivity and predicts the development of type 2 diabetes[J].Diabetes, 2002, 51 (6) :1889-1895.
|
|
[29]Wanless IR, Lentz JS.Fatty liver hepatitis (steatohepatitis) and obesity:an autopsystudy with analysis of risk factors[J].Hepatology, 1990, 12 (5) :1106-1110.
|
|
[29]Wanless IR, Lentz JS.Fatty liver hepatitis (steatohepatitis) and obesity:an autopsystudy with analysis of risk factors[J].Hepatology, 1990, 12 (5) :1106-1110.
|
|
[30]Shibata M, Kihara Y, Taguchi M, et al.Nonalcoholic fatty liv-er disease is a risk factor for type 2 diabetes in middle-agedjapanese men[J].Diabetes Care, 2007, 30 (11) :2940-2944.
|
|
[30]Shibata M, Kihara Y, Taguchi M, et al.Nonalcoholic fatty liv-er disease is a risk factor for type 2 diabetes in middle-agedjapanese men[J].Diabetes Care, 2007, 30 (11) :2940-2944.
|
|
[31]Targher G, Bertolini L, Poli F, et al.Nonalcoholic fatty liverdisease and risk of future cardiovascular events among type 2diabetic patients[J].Diabetes, 2005, 54 (12) :3541-3546.
|
|
[31]Targher G, Bertolini L, Poli F, et al.Nonalcoholic fatty liverdisease and risk of future cardiovascular events among type 2diabetic patients[J].Diabetes, 2005, 54 (12) :3541-3546.
|
|
[32]Targher G, Bertolini L, Rodella S, et al.Nonalcoholic fattyliver disease is independently associated with an increasedincidence of cardiovascular events in type 2 diabetic patients[J].Diabetes Care, 2007, 30 (8) :2119-212.
|
|
[32]Targher G, Bertolini L, Rodella S, et al.Nonalcoholic fattyliver disease is independently associated with an increasedincidence of cardiovascular events in type 2 diabetic patients[J].Diabetes Care, 2007, 30 (8) :2119-212.
|
|
[33]Brea A, Mosquera D, Martín E, et al.Nonalcoholic fatty liverdisease is associated with carotid atherosclerosis:a case-control study[J].Arterioscler Thromb Vasc Biol, 2005, 25 (5) :1045-1050.
|
|
[33]Brea A, Mosquera D, Martín E, et al.Nonalcoholic fatty liverdisease is associated with carotid atherosclerosis:a case-control study[J].Arterioscler Thromb Vasc Biol, 2005, 25 (5) :1045-1050.
|
|
[34]Assy N, Djibre A, Farah R, et al.Presence of coronaryplaques in patients with nonalcoholic fatty liver disease[J].Radiology, 2010, 254 (2) :393-400.
|
|
[34]Assy N, Djibre A, Farah R, et al.Presence of coronaryplaques in patients with nonalcoholic fatty liver disease[J].Radiology, 2010, 254 (2) :393-400.
|
|
[35]Choi SY, Kim D, Kim HJ, et al.The relation between non-alcoholic fatty liver disease and the risk of coronary heart dis-ease in Koreans[J].Am J Gastroenterol, 2009, 104 (8) :1953-1960.
|
|
[35]Choi SY, Kim D, Kim HJ, et al.The relation between non-alcoholic fatty liver disease and the risk of coronary heart dis-ease in Koreans[J].Am J Gastroenterol, 2009, 104 (8) :1953-1960.
|
|
[36]Roberts EA.Pediatric Nonalcoholic fatty liver disease (NAFLD) :A“growing”problem[J].J hepatol, 2007, 46 (6) :1133-1142.
|
|
[36]Roberts EA.Pediatric Nonalcoholic fatty liver disease (NAFLD) :A“growing”problem[J].J hepatol, 2007, 46 (6) :1133-1142.
|
|
[37]Valerio Nobili, Matilde Marcellini, Rita Devito, et al.NAFLDin children:a prospective Cli nical-pathological study andeffect of lifestyle advice[J].Hepatology, 2006, 44 (2) :458-465.
|
|
[37]Valerio Nobili, Matilde Marcellini, Rita Devito, et al.NAFLDin children:a prospective Cli nical-pathological study andeffect of lifestyle advice[J].Hepatology, 2006, 44 (2) :458-465.
|
|
[38]Patton HM, Yates K, Unalp-Arida A, et al.Association be-tween metabolic syndrome and liver histology among childrenwith nonalcoholic fatty liver disease[J].Am J Gastroenterol, 2010, 105 (9) :2093-2102.
|
|
[38]Patton HM, Yates K, Unalp-Arida A, et al.Association be-tween metabolic syndrome and liver histology among childrenwith nonalcoholic fatty liver disease[J].Am J Gastroenterol, 2010, 105 (9) :2093-2102.
|
|
[39]Ratziu V, Bellentani S, Cortez-Pinto H, et al.A positionstatement on NAFLD/NASH based on the EASL 2009 specialconference[J].J Hepatol, 2010, 53 (2) :372-384.
|
|
[39]Ratziu V, Bellentani S, Cortez-Pinto H, et al.A positionstatement on NAFLD/NASH based on the EASL 2009 specialconference[J].J Hepatol, 2010, 53 (2) :372-384.
|
PDF下载 ( 1170 KB)
本文二维码
下载:
